Basis: Unrounded diluted TTM EPS / FMP quote price × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The earnings yield is N/A as of 2026-10-06T16:40:55.530Z.
Calculation as of: 2026-10-06T16:40:55.530Z.
Quote observation: 2026-10-06T16:40:17.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 29544bddba9647c45f1d116a926e76fce0232fba061b4e126f75ac7ab8440d73
EARNINGS YIELD
N/A
Market Cap
$841.18M
Earnings Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$838.62M
Earnings Yield
N/A
TTM Avg
0.29%
3Y Avg
0.29%
5Y Avg
0.29%
Market Cap
$846.48M
Earnings Yield
N/A
TTM Avg
2.16%
3Y Avg
2.16%
5Y Avg
2.16%
Market Cap
$850.70M
Earnings Yield
N/A
TTM Avg
3.42%
3Y Avg
14.26%
5Y Avg
9.75%
| NAME | MARKET CAP | EARNINGS YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Beta Bionics, Inc. (BBNX) | $840.18M | N/A | N/A | N/A | N/A |
| SpyGlass Pharma, Inc. Common Stock (SGP)vs › | $841.18M | N/A | N/A | N/A | N/A |
| Pacific Biosciences of California, Inc. (PACB)vs › | $838.62M | N/A | 0.29% | 0.29% | 0.29% |
| Alumis Inc. (ALMS)vs › | $843.00M | N/A | N/A | N/A | N/A |
| Monte Rosa Therapeutics, Inc. (GLUE)vs › | $846.48M | N/A | 2.16% | 2.16% | 2.16% |
| QuidelOrtho Corporation (QDEL)vs › | $850.70M | N/A | 3.42% | 14.26% | 9.75% |
| SL Science Holding Ltd (SLBT)vs › | $852.35M | N/A | N/A | N/A | N/A |
| Jade Biosciences, Inc. (JBIO)vs › | $819.17M | N/A | N/A | N/A | N/A |
| SI-BONE, Inc. (SIBN)vs › | $866.41M | N/A | N/A | N/A | N/A |
| Ardelyx, Inc. (ARDX)vs › | $808.43M | N/A | 0.51% | 0.51% | 0.51% |
Earnings Yield
N/A
EPS ÷ Price
P/E Ratio
N/A
Price ÷ EPS
Formula: Earnings Yield = (EPS / Price) × 100
Earnings Yield is simply the inverse of P/E. A P/E of 20 equals a 5% earnings yield.
How earnings yield is used:
Earnings Yield = EPS (TTM) / Share Price
Earnings yield is the inverse of the PE ratio, expressing trailing earnings as a percentage of price. Higher is cheaper.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
